Slideshow

Study Upends Pro Fish Consumption Theory in Rheumatoid Arthritis

Despite years of research that show omega-3 fatty acids from specific fish species can improve rheumatoid arthritis (RA) symptoms and even protect at-risk patients from developing RA, a new study of 3,863,909 person-years published in BMC Musculoskeletal Disorders finds no benefit.

Despite years of research that show omega-3 fatty acids from specific fish species can improve rheumatoid arthritis (RA) symptoms and even protect at-risk patients from developing RA, a new study of 3,863,909 person-years published in BMC Musculoskeletal Disorders finds no benefit.“In this large prospective cohort study, we found no clear protective effect of fish or marine omega-3 fatty acid intake on RA risk, overall or by serologic status,” wrote researchers who were led by Jeffrey A. Sparks, M.D., of Brigham and Women’s Hospital in Boston.Dr. Sparks and colleagues compared the risk of developing rheumatoid arthritis and fish intake. They also considered smoking status finding some evidence that suggests fish consumption lessened the association of smoking and the onset of rheumatoid arthritis. Learn more in this slideshow.

References:

Jeffery A. Sparks, Eilis J. O’Reilly, Medha Barbhaiya, et al. Association of fish intake and smoking with risk of rheumatoid arthritis and age of onset: a prospective cohort study. BMC Musculoskeletal Disorders (2019) 20:2. https://doi.org/10.1186/s12891-018-2381-3

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.